FACULTY
Navigating Critical Pathways: Ensuring Optimal Management of Acute Coronary Syndrome
Activity Date: August 2007  — Activity Info: Volume 4, (7)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 
FULL DISCLOSURE POLICY AFFECTING CE ACTIVITIES
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR
Robert B. Parker, PharmD, FCCP
Professor
University of Tennessee
Department of Clinical Pharmacy
Memphis, Tennessee
Dr Parker reports receiving grants/research support from AstraZeneca.

PARTICIPATING FACULTY
Judy W. M. Cheng, PharmD, MPH, BCPS, FCCP
Associate Professor of Pharmacy Practice
Long Island University
Long Island, New York
Clinical Pharmacy Specialist of Cardiology
Mount Sinai Medical Center
New York, New York
Dr Cheng reports having no significant financialor advisory relationships with corporate organizations related to this activity.

Paul P. Dobesh, PharmD, FCCP, BCPS
Associate Professor
Department of Pharmacy Practice
University of Nebraska College of Pharmacy
Omaha, Nebraska
Dr Dobesh reports serving as a consultant for Bristol-Myers Squibb, The Medicines Company, and Sanofi-Aventis.

Kerry K. Pickworth, PharmD
Specialty Practice Pharmacist, Cardiology
Richard M. Ross Heart Hospital
The Ohio State University Medical Center
Columbus, Ohio
Dr Pickworth reports serving as a consultant for ARCA Discovery, Inc and University Pharmacotherapy Associates; and receiving honoraria from The Medicines Company.

Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that articles in this continuing pharmaceutical education activity contain no reference(s) to unlabeled or unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.
     
Home | Contact Us | View Account | Need Help?